Sunder Biomedical Tech Co

Sunder Biomedical Tech Co Debt

The Debt of Sunder Biomedical Tech Co (4115.TWO) as of Oct 22, 2026 is 132.24 M TWD. In the previous year, Debt was 401.47 M TWD — a change of -67.06% (lower).

Debt

132.24 MTWD

YoY

-67.06%

Last updated:

In 2025, Sunder Biomedical Tech Co's total debt was 132.24 M TWD, a -67.06% change from the 401.47 M TWD total debt recorded in the previous year.

The Sunder Biomedical Tech Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2019
345.07 M TWD
Jan 1, 2020
599.78 M TWD
Jan 1, 2021
526.90 M TWD
Jan 1, 2022
476.55 M TWD
Jan 1, 2023
491.29 M TWD
Jan 1, 2024
401.47 M TWD
Jan 1, 2025
132.24 M TWD
The Sunder Biomedical Tech Co Debt history
YEARDebtYoY
132.24 MTWD-67.06%
401.47 MTWD-18.28%
491.29 MTWD+3.09%
476.55 MTWD-9.56%
526.90 MTWD-12.15%
599.78 MTWD+73.81%
345.07 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co Ltd manufactures and sells medical consumables including blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, and protective covers. The company also produces laparoscopic smoke filters, suction sets, pick-up bags, and medical grade materials such as PVC pellets, NON-diethylhexyl phthalate (DEHP) PVC, and other medical components. Additionally, Sunder Biomedical offers sterilization and laboratory services, along with foundry services for masks, tubes, and nucleic acid extraction well tray consumables. The primary buyers of Sunder Biomedical's products are healthcare facilities, hospitals, and medical institutions requiring disposable medical equipment and supplies. These clients purchase medical consumables for routine procedures, surgical operations, and patient care. The company's focus on medical grade materials ensures compliance with healthcare standards, making its products essential for medical professionals. Sunder Biomedical's revenue streams include direct sales of medical consumables, sterilization services, and foundry services for specialized medical components. The company targets the healthcare sector, particularly hospitals and clinics, where demand for reliable, high-quality disposable medical products is consistent. By providing a comprehensive range of medical supplies, Sunder Biomedical caters to the operational needs of healthcare providers across various medical specialties. Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Sunder Biomedical Tech Co's Debt Structure

Sunder Biomedical Tech Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Sunder Biomedical Tech Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Sunder Biomedical Tech Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Sunder Biomedical Tech Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

Debt of Sunder Biomedical Tech Co is 132.24 M TWD in 2025.

Debt of Sunder Biomedical Tech Co changed from 401.47 M TWD to 132.24 M TWD, representing a -67.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Sunder Biomedical Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co